MedPath

Effect of Aragvadhadi Taila and gel in Shvitra

Phase 2
Conditions
Health Condition 1: null- patients having signs and symptoms of Shvitra (Vitiligo)Health Condition 2: L80- Vitiligo
Registration Number
CTRI/2018/01/011120
Lead Sponsor
Institute for Post Graduate Teaching and Research in Ayurveda
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Patients having signs and symptoms of Shvitra (vitiligo).

2. Patient between the age-18 to 60 years.

3. Patients with chronicity of less than 10 years

Exclusion Criteria

1. Patients with Chronicity more than 10 years.

2. Patients having serious cardiac, renal, hepatic diseases, major illness like IDDM, NIDDM, patches due to burning, chemical explosion, any other serious systemic illness.

3. Gravid and lactating women.

•Women in fertile age planning for conception within next 3 months.

•Cases with Asadhya Lakshana of Shvitra

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1 Marked improvement in Vitiligo patches and <br/ ><br>other clinical features <br/ ><br>2 complete remission of Vitiligo lesions <br/ ><br>3 Non recurrence after the follow up periodTimepoint: 56 days
Secondary Outcome Measures
NameTimeMethod
1 Improvement in skin texture <br/ ><br>2 Improvement in Dermatological QOLTimepoint: 28 days
© Copyright 2025. All Rights Reserved by MedPath